← Evidence map

ReviewJournal of clinical pharmacy and therapeutics2022

Treatment and economic burden of mucormycosis in China: Case report review and burden estimation.

Yifei Jian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35304764